BioCatalyst

IDX-1197+XELOX, IDX-1197+Irinotecan — catalyst calendar

1 verified catalyst event(s) referencing IDX-1197+XELOX, IDX-1197+Irinotecan, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07-31
in 1mo
ESTIMATED
 READOUT
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combinatio
Phase 1/2 · Gastric Cancer
 Idience Co., Ltd. IDX-1197+XELOX, IDX-1197+Irinotecan ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.